（文章来源：证券日报） 证券日报网讯 9月11日晚间，夏厦精密发布公告称，公司于2025年9月11日召开职工代表大会，经全体 与会职工代表表决，同意选举谢桂平先生担任公司第二届董事会职工代表董事。 ...

浙江夏厦精密制造股份有限公司 关于董事辞职暨选举职工代表董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事辞职情况 浙江夏厦精密制造股份有限公司（以下简称"公司"）董事会近日收到公司 非独立董事夏爱娟女士递交的书面辞职报告。因公司治理结构调整，夏爱娟女士 申请辞去公司第二届董事会董事、薪酬与考核委员会委员职务，辞去上述职务后， 夏爱娟女士将继续在公司担任副总经理职务。夏爱娟女士原任期至第二届董事会 任期届满之日，即 2026 年 10 月 10 日。根据《公司法》《深圳证券交易所上市 公司自律监管指引第 1 号——主板上市公司规范运作》《公司章程》等有关规定， 夏爱娟女士的辞职不会导致公司董事会成员低于法定最低人数，并已按照公司相 关规定做好离任交接工作，不会影响公司董事会的正常运作，其辞职报告自送达 董事会时生效。公司将根据相关规定尽快完成薪酬与考核委员会委员的补选工 作。 截至本公告披露日，夏爱娟女士未直接持有公司股票，通过控股股东宁波夏 厦投资控股有限公司间接持有公司股票。夏爱娟女士离任公司非独立董事职务 后，将继续遵守《上市公司董事和 ...

证券代码：001306 证券简称：夏厦精密 公告编号：2025-047 浙江夏厦精密制造股份有限公司 2025 年第三次临时股东大会决议公告 3、 召开方式：现场结合网络 4、 召集人：公司第二届董事会 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 一、会议召开和出席情况 1、 召开时间： （1）现场会议：2025 年 9 月 11 日（星期四）14:30 （2）网络投票： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 9 月 11 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00； 通过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn）投票的具体 时间为：2025 年 9 月 11 日 9:15-15:00 期间任意时间。 2、 现场会议召开地点：浙江省宁波市镇海区骆驼工业区荣吉路 389 号浙 江夏厦精密制造股份有限公司二楼会议室。 5、 主持人：董事长夏建敏先生 6、 本次会议的召集、召开符合《中华人民共和国公司法》、《上市公司 股东会规则》、《深圳证券 ...

上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于 浙江夏厦精密制造股份有限公司 2025 年第三次临时股东大会 的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于浙江夏厦精密制造股份有限公司 2025 年第三次临时股东大会的 法律意见书 致：浙江夏厦精密制造股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受浙江夏厦精密制造股份 有限公司（以下简称"公司"）委托，就公司召开 2025 年第三次临时股东大会（以 下简称"本次会议"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《上市公司股东会规则》等法律、法规、规章和其他规范性文件以及《浙 江夏厦精密制造股份有限公司章程》（以下简称"《公司章程》"）的有关规定， 出具本法律意见书。 为出具本法律意见书，本所律师对本次会议所涉及的相关事项进行了必要的 核查和验证，审查了本所律师认为出具本法律意见书所需审查的相关文件、资料， 并参加 ...

Group 1 - The humanoid robot concept stocks are experiencing a significant surge, with Ampere Dragon hitting a 20% limit up during trading [1] - Several companies, including Qin Chuan Machine Tool, Bojie Co., Zhejiang Rongtai, and Wuzhou New Spring, have also reached their limit up [1] - Other notable gainers in the sector include Aifute, Xiaxia Precision, and Haon Automotive Electric, which are showing substantial increases in their stock prices [1]

Investment Rating - The report maintains an "Accumulate" rating for the company [7] Core Views - The company achieved a revenue growth of 30.77% year-on-year in H1 2025, driven by active market expansion, with total revenue reaching 374 million yuan [1][2] - The net profit attributable to the parent company decreased by 41.87% year-on-year, primarily due to intensified price competition in the domestic automotive market and increased fixed costs from ongoing fundraising projects [1][3] Revenue and Profit Analysis - In H1 2025, the company's revenue from automotive gears, electric tool gears, reducers, and other equipment was 199 million, 68 million, 87 million, and 19 million yuan respectively, with year-on-year growth rates of 22.35%, 6.26%, 101.69%, and 22.35% [2] - The gross margin and net margin for H1 2025 were 18.96% and 5.50%, down by 3.23 and 3.83 percentage points compared to the full year of 2024 [3] R&D and Technological Advancements - The company has developed core technologies for ultra-hard, ultra-fine high-speed cutting hard alloy gear hobs, achieving an industry-leading minimum modulus of 0.05mm, which meets the high-precision gear processing needs of industries such as robotics [4] - The development of core equipment for planetary roller screw processing is on track, with plans for further optimization to achieve mass production and cost reduction [4] Future Growth Prospects - The company is investing in a project in Vietnam to produce 1 million sets of precision transmission structure products annually, with part of the production equipment already installed and in trial production [5][12] - Revenue forecasts for 2025, 2026, and 2027 are projected at 765 million, 854 million, and 956 million yuan, with year-on-year growth rates of 14.9%, 11.7%, and 11.9% respectively [13]

Group 1 - The core viewpoint of the news is that Hongdao Investment has conducted research on a listed company, Xiaxia Precision, revealing significant growth in revenue but a decline in net profit due to various competitive and cost factors [1] - Xiaxia Precision's revenue is projected to grow by 30.77% in the first half of 2025, while net profit is expected to decrease by 41.87% [1] - The company is experiencing over 100% growth in its reducer business, attributed to increased order volumes following customer validation [1] Group 2 - Xiaxia Precision plans to expand its product line to include joint module products and increase R&D investment [1] - The company is making progress in the development of core processing equipment for lead screws, enhancing precision and efficiency [1] - Xiaxia Precision has initiated trial production at a new factory in Vietnam and aims to expand into overseas markets [1] Group 3 - The company is advancing its core components project for intelligent transmission systems, with diverse funding sources [1]

Group 1: Xiasha Precision (001306) - In the first half of 2025, Xiasha Precision's revenue increased by 30.77%, while net profit decreased by 41.87% due to price competition, rising costs, and interest changes [1] - The company's products, such as precision gears and reducers, have been applied in humanoid robots, although the order scale remains small [1] - The reducer business grew over 100%, benefiting from customer validation and subsequent volume increase [1] - Future plans include expanding the joint module product line and increasing R&D investment [1] - The core processing equipment for lead screws is progressing well, with improvements in precision and efficiency [1] - A factory has been established in Vietnam for trial production, with plans to expand into overseas markets [1] - The core components project for intelligent transmission systems is underway, with diverse funding sources [1] Group 2: Cambridge Technology (603083) - The company's main business with North American operators focuses on broadband access and wireless networks, with unclear business planning for 2027 [2] - Progress varies with multiple North American major clients, with some product validations nearing completion while others are still ongoing [2] - The production capacity for the 800G series products at Shanghai and Jiashan factories is set to increase to an annualized 2 million units, with further expansion planned for the first half of next year [2] - This year's expansion plan is progressing smoothly, with next year's capacity targets raised compared to previous expectations [2] - The current expansion relies on internal funds, while next year may involve financing through Hong Kong issuance, with sufficient material reserves to meet this year's demand [2]

Group 1: Zhaoyi Innovation - Zhaoyi Innovation reported good growth across all business lines in Q2 2024, with NOR Flash growing in the high single digits, niche DRAM growing over 50%, and MCU close to 20% [1] - The company expects significant revenue growth in niche DRAM in the second half of the year, with contract prices continuing to rise [1] - The demand for NOR Flash is increasing due to a rise in electronic product code volume, while supply remains tight due to wafer manufacturing capacity constraints [1] Group 2: Teabo Bio - Teabo Bio is focusing on functional cure for hepatitis B through a combination of different mechanism drugs with interferons and nucleoside analogs [2] - The company aims to provide comprehensive management of hepatitis B through a wide-reaching clinical cure network [2] - Collaboration with Ligos is underway to explore reinfection control after clearing infected cells [2] Group 3: Ruijie Networks - Ruijie Networks saw significant revenue growth in data center products, primarily driven by internet clients, with over 90% of revenue coming from this sector [3] - The company anticipates continued strong demand for cloud computing infrastructure in the second half of the year [3] - The gross margin for data center products is relatively low (15%-20%), while margins in enterprise and SMB markets have improved [3] Group 4: Trina Solar - Trina Solar is focusing on maintaining fair competition in the photovoltaic industry and promoting healthy development [4] - The company aims for over 8GWh in the storage segment for the year, with an increasing proportion of overseas orders [4] - The demand in the U.S. market is accelerating, leading to increased component prices and optimized supply chains [4] Group 5: Liangxin Co. - Liangxin Co. has segmented its data center business into three main areas: internet enterprises, operators, and individual projects, with a focus on HVDC and UPS [5] - The company is expected to continue its efforts in digital energy and infrastructure despite a potential slowdown in the renewable energy sector [5] - The gross margin for overseas business has slightly decreased compared to the previous year [5] Group 6: Baillie Tianheng - Baillie Tianheng is advancing three key overseas clinical trials for treating triple-negative breast cancer, EGFR-mutant non-small cell lung cancer, and urothelial carcinoma [6] - The company has submitted its first nuclear medicine candidate drug for domestic IND application [6] - R&D expenses reached 1.038 billion yuan by mid-year, with expectations for future clinical research costs to increase [6] Group 7: Jingfeng Mingyuan - Jingfeng Mingyuan has achieved an increase in overall gross margin through cost reduction and efficiency improvements [7] - The company is expanding its market presence in smart LED lighting products despite a decline in sales and prices in traditional LED lighting [7] - The high-performance computing power supply chip business has seen rapid growth, with products entering large-scale sales [7] Group 8: Chipone - Chipone is providing various customized hardware and software solutions in the AI field, serving multiple international giants [8] - The company has a high percentage of R&D personnel, with 89.31% of staff engaged in research and development [8] - Chipone is advancing Chiplet technology and has achieved success in designing high-performance automotive chips [8] Group 9: Xiasha Precision - Xiasha Precision reported a 30.77% increase in revenue for the first half of 2025, but a 41.87% decline in net profit due to price competition and rising costs [9] - The company plans to expand its product line in joint modules and increase R&D investment [9] - A new factory in Vietnam is under trial production, with plans to expand into overseas markets [9] Group 10: Lepu Medical - Lepu Medical's subsidiary focuses on elderly care services and has developed a facial filler product that has received regulatory approval [10] - The company is advancing AI products that monitor vital signs through various hardware applications [10] - Lepu Medical has a significant asset management scale, ranking 14th among 210 in public fund management [10]

Group 1: Financial Performance - In the first half of 2025, the company achieved a revenue of 373.73 million CNY, a year-on-year increase of 30.77% [2] - The net profit attributable to shareholders was 20.57 million CNY, a decline of 41.87% compared to the same period last year [2] - The net profit excluding non-recurring gains and losses was 18.50 million CNY, down 40.32% year-on-year [2] Group 2: Reasons for Revenue Growth and Profit Decline - Revenue growth was driven by market expansion and product innovation [2] - Profit decline was attributed to intensified price competition in the automotive sector, increased fixed costs from asset depreciation and personnel expenses, and reduced financial income due to decreased funds and increased borrowing [2] Group 3: Product Development and Market Applications - The company has developed precision gears, reducers, and screw products for humanoid robots, with existing orders being small-scale [3] - The reducer and other business segments saw over 100% growth due to successful applications in robotics [4][5] Group 4: Future Plans and Investments - The company plans to expand its product line to include joint modules through self-research or acquisitions [5] - A new production line has been established in Vietnam, with equipment in trial production [6] - The company has acquired land for a new project aimed at producing precision gears and reducers, with funding sourced from self-owned funds and bank loans [6] Group 5: Risk Considerations - The company emphasizes that future projections and targets discussed do not constitute substantive commitments, urging investors to maintain adequate risk awareness [6]